AnaptysBio Q3 EPS $0.52 Beats $(1.42) Estimate, Sales $76.320M Beat $15.811M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $(1.42) by 136.65 percent. This is a 145.61 percent increase over losses of $(1.14) per share from the
